EN
[{"Id":969564183899148288,"parent_id":0,"name":"走进奥浦迈","code":"about","description":"","order_path":"01_03"},{"Id":969563762778443776,"parent_id":0,"name":"细胞培养解决方案","code":"solution","description":"包括商业化培养基和定制化培养基,同时提供指定配方委托生产服务","order_path":"01_06"},{"Id":987390916945776640,"parent_id":0,"name":"CRDMO服务","code":"crdmo","description":"CDMO服务由思伦生物承接,为生物药的研发和生产提供端到端整体解决方案。\nCRO服务由澎立生物承接,可向全球创新生物医药企业提供定制化的早期\n筛选、临床前药效学、药代动力学和以及符合国际规范的安全性评价服务","order_path":"01_07"},{"Id":969563978185314304,"parent_id":0,"name":"服务支持","code":"service","description":"","order_path":"01_08"},{"Id":969564295945785344,"parent_id":0,"name":"投资者关系","code":"investor","description":"","order_path":"01_09"},{"Id":969564416255201280,"parent_id":0,"name":"加入我们","code":"joinus","description":"","order_path":"01_10"}]

[{"Id":970629000307150848,"parent_id":969564183899148288,"name":"企业概况","code":"about_company","description":"","order_path":"01_00,02_01"},{"Id":970629300032114688,"parent_id":969564183899148288,"name":"社会责任","code":"about_social","description":"","order_path":"01_00,02_02"},{"Id":970629435122257920,"parent_id":969564183899148288,"name":"新闻资讯","code":"about_news","description":"","order_path":"01_00,02_03"},{"Id":970629590022098944,"parent_id":969564183899148288,"name":"联系我们","code":"about_contact","description":"","order_path":"01_00,02_04"},{"Id":969564183899148288,"parent_id":0,"name":"走进奥浦迈","code":"about","description":"","order_path":"01_03"},{"Id":969563893141606400,"parent_id":987390916945776640,"name":"端到端CDMO","code":"cdmo","description":"完善的细胞系构建、工艺开发和抗体质量分析平台","order_path":"01_03,02_01"},{"Id":969261587930025984,"parent_id":987390916945776640,"name":"CRO服务","code":"cro_service","description":"专注于提供符合国际标准的","order_path":"01_03,02_02"},{"Id":970845240518774784,"parent_id":969563978185314304,"name":"培养基指南","code":"service_guidelines","description":"","order_path":"01_04,02_01"},{"Id":970845464477831168,"parent_id":969563978185314304,"name":"资料下载","code":"service_download","description":"","order_path":"01_04,02_02"},{"Id":970845592412491776,"parent_id":969563978185314304,"name":"COA查询","code":"service_coa","description":"","order_path":"01_04,02_03"},{"Id":970845812282101760,"parent_id":969563978185314304,"name":"参考文献","code":"service_reference","description":"","order_path":"01_04,02_04"},{"Id":969563762778443776,"parent_id":0,"name":"细胞培养解决方案","code":"solution","description":"包括商业化培养基和定制化培养基,同时提供指定配方委托生产服务","order_path":"01_06"},{"Id":970842632362135552,"parent_id":969564295945785344,"name":"股票信息","code":"investor_stock","description":"","order_path":"01_06,02_01"},{"Id":970843817206878208,"parent_id":969564295945785344,"name":"公司公告","code":"investor_notice","description":"","order_path":"01_06,02_03"},{"Id":987390916945776640,"parent_id":0,"name":"CRDMO服务","code":"crdmo","description":"CDMO服务由思伦生物承接,为生物药的研发和生产提供端到端整体解决方案。\nCRO服务由澎立生物承接,可向全球创新生物医药企业提供定制化的早期\n筛选、临床前药效学、药代动力学和以及符合国际规范的安全性评价服务","order_path":"01_07"},{"Id":970844184980230144,"parent_id":969564416255201280,"name":"工作在奥浦迈","code":"joinus_growing","description":"","order_path":"01_07,02_01"},{"Id":970844418766540800,"parent_id":969564416255201280,"name":"薪酬福利","code":"joinus_benefits","description":"","order_path":"01_07,02_02"},{"Id":970844588690378752,"parent_id":969564416255201280,"name":"员工活动","code":"joinus_activities","description":"","order_path":"01_07,02_03"},{"Id":970844841434943488,"parent_id":969564416255201280,"name":"人才招聘","code":"joinus_recruitment","description":"","order_path":"01_07,02_04"},{"Id":969563978185314304,"parent_id":0,"name":"服务支持","code":"service","description":"","order_path":"01_08"},{"Id":969564295945785344,"parent_id":0,"name":"投资者关系","code":"investor","description":"","order_path":"01_09"},{"Id":969564416255201280,"parent_id":0,"name":"加入我们","code":"joinus","description":"","order_path":"01_10"}]

ABOUT US

关于奥浦迈

探索更多
上海奥浦迈生物科技股份有限公司(以下简称“奥浦迈”或“公司”,股票代码:688293) 成立于2013年,是一家专注于提供细胞培养解决方案和端到端CRDMO服务的高新技术企业。奥浦迈拥有4个符合GMP标准的生产基地,总面积超18,000平方米,质量管理体系获得ISO9001:2015认证(德国TÜV NORD)以及ISO13485:2016质量体系认证(瑞士SGS公司)。另有总面积约30,000平方米的新总部正处于建设阶段。此外,旗下子公司澎立生物医药技术(上海)股份有限公司(以下简称“澎立生物”)设有5个实验室,合计面积约42,000平方米。至此,奥浦迈连同子公司现有研发生产总面积已超过60,000平方米。

8000

符合GMP标准的培养基生产基地

10000

端到端CDMO平台

42000

CRO平台运营及实验基地

2000 +

累计服务2000+家客户

350 +

国内使用奥浦迈细胞培养基产品的药品研发管线,截至20260331

END-TO-END CDMO

端到端CDMO

探索更多
01
抗体药物发现
02
稳定细胞系构建
03
细胞库建库
04
细胞培养工艺开发
05
纯化工艺开发
06
制剂工艺开发
07
生产
08
产能
09
质量分析和表征

OPM STOCK

奥浦迈科创板上市

奥浦迈 :688293
0

0 〔0〕

Copyright © 2026 上海奥浦迈生物科技股份有限公司 All Rights Reserved. 沪ICP备14035147号-3 沪公网安备31011502403988号

Trial equipment application

试用装申请

申请样品类型
  • 稳转CHO平台
  • 转染试剂
  • 瞬转表达平台
  • CryoStasis™组织/细胞冻存液
  • 疫苗平台
  • 杂交瘤平台
  • 经典培养基
  • 细胞治疗平台
    联系信息